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Chemotaxis  by  a  macrophage  cell  line, RAW264, is 
specifically  inhibited  by  the  intracellular  accumulation 
of 3-deazaadenosylhomocysteine (3-deaza-AdoHcy).  In- 
tracellular  accumulation  of  3-deaza-AdoHcy is the  re- 
sult of  incubation  of  the cells with  3-deazaadenosine,  a 
compound  that  can  function  both as a  substrate and as 
an  inhibitor  of  adenosylhomocysteine  (AdoHcy)  hydro- 
lase.  Accumulation  of AdoHcypw se, brought  about in 
chemotactic cell lines by  incubation  with  either  3-de- 
azaadenosine or with 3-deazaaristeromycin, does not 
affect  chemotaxis. 
The specific  role of 3-deazaadenosine as an inhibitor 
of  macrophage  cell  line  chemotaxis is supported  by  the 
following  findings.  Another  macrophage  cell  line, 
RAW309CR, is resistant to  the  inhibition of chemotaxis 
by 3-deazaadenosine, and the resistance can be as- 
cribed to the  failure to accumulate  3-deaza-AdoHcy  in 
this cell line.  It is noteworthy that both RAW264  and 
RAW309CR accumulate similar amounts of AdoHcy 
after  incubation  with  3-deazaadenosine.  The  difference 
in the accumulation  of  3-deaza-AdoHcy in RAW264  and 
RAW309CR is explained by the  finding  that sonicates 
of RAW264 rapidly  form  3-deaza-AdoHcy  but sonicates 
of RAW309CR  do not.  Both  hydrolysis  of  AdoHcy  and 
the  inhibition of the  hydrolysis  of AdoHcy  by  3-deaza- 
adenosine  are  the  same in sonicates of the two macro- 
phage  cell lines. 
The discovery by Adler and Dahl (1) that methionine is 
required for bacterial chemotaxis led to  a series of important 
studies on the role of methylation in chemotaxis. In vivo 
studies in Escherichia coli and Salmonella typhimurium 
established that  the normal response to chemotactic stimuli 
depends on carboxymethylation of methyl-accepting chemo- 
taxis proteins (2-9). Attempts  to establish whether methyla- 
tion reactions are analogously  involved  in eukaryotic chemo- 
taxis have produced conflicting results. Protein carboxymeth- 
ylation was stimulated by attractants in rabbit neutrophils 
(lo), but carboxymethylation in guinea  pig macrophages was 
not affected (11). On the other hand, incorporation of the 
methyl group of methionine into phosphatidylcholine was 
inhibited by attractant in both guinea pig macrophages (11) 
and rabbit neutrophils (12). These studies employed  cells that 
were heterogeneous both in regard to cell type and cellular 
behavior. For example,  only a fraction of human monocytes 
(20-40%) normally exhibit chemotaxis (13). Since the bio- 
chemical studies have used heterogeneous cell populations, 
* The costs of publication of this article were defrayed in part by 
the payment of page charges. This article  must therefore be hereby 
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solely to indicate this  fact. 
precise correlation of biochemical events with the migrating 
cells remains undetermined. 
In eukaryotes, intracellular methylations can be inhibited 
by decreasing the S-adenosylmethionine/S-adenosylhomo- 
cysteine ratio (14). AdoHcy’ is a product inhibitor of all 
reactions that utilize  AdoMet as methyl donor. The principal 
reaction for which AdoHcy is a substrate is catalyzed by 
AdoHcy hydrolase (EC 3.3.1.1), an enzyme first discovered by 
de la Haba and Cantoni (15). The reaction is reversible and 
equilibrium favors the direction of synthesis. 3-Deazaadeno- 
sine, an analog of adenosine, is both a potent inhibitor of 
AdoHcy hydrolase and a  substrate of this enzyme,  yielding in 
vitro a congener of AdoHcy,  namely  3-deaza-AdoHcy (16). As 
a consequence of the intracellular accumulation of AdoHcy 
and 3-deaza-AdoHcy, the AdoMet/AdoHcy (or AdoMet/ 
AdoHcy + 3-deaza-AdoHcy) ratio decreases and in vivo meth- 
ylation can be inhibited (14,  16-20). 
In this paper, we show for the  fist time that inhibition of 
chemotaxis by a macrophage cell line (21) is due specifically 
to  the intracellular accumulation of 3-deaza-AdoHcy. 
MATERIALS AND METHODS 
Cells-Mouse macrophage cell lines RAW264 and RAW309CR 
were obtained from the Cell Distribution Center, Salk Institute, San 
Diego, CA and cultured in MEM containing 10% heat-inactivated 
(56 “C for 30 min) fetal calf serum, 100 international units/ml of 
penicillin and 100 Ig/ml of streptomycin as described previously (21). 
The day before an experiment, the cells were scraped into the medium 
and centrifuged at  150 X g for 10 min. The cell pellet was resuspended 
in MEM containing 10% heat-inactivated fetal calf serum at a con- 
centration of 7.5 X lo5 viable cells/ml, and 4 ml were added to 6-cm 
dishes. Viable cells were determined by trypan blue exclusion. 
Chemotaxis Assay-Migration of macrophage cell lines across a 
10-pm thick Nucleopore polycarbonate filter containing 5-pm holes 
was measured in a 48-well chemotaxis chamber as described previ- 
ously (21,22). The  top wells contained 50,000 cells in MEM with 10% 
heat-inactivated  fetal calf serum,  and the bottom wells contained a 1: 
100 dilution of endotoxin-activated mouse serum (23) in RPMI 1640 
medium. After incubation for 4  h at 37 OC in an atmosphere of 5% 
COZ,  95% air, the migrated cells were counted. Assays  were performed 
in duplicate and the standard  error was less than 20% when more 
than 100 cells were counted. In most experiments, less than 1% of the 
input cells migrated in the absence of attractant. Because of the error 
in counting low numbers of cells, the effect of 3-deazaadenosine on 
the migration in the absence of the  attractant was not studied. 
Determination of AdoMet, AdoHcy, and 3-deaza-AdoHcy-Cells 
groing in 6-cm dishes were incubated in 3 ml of MEM containing 5 
pCi/ml of [35S]methionine (Amersham/Searle). The specific activity 
of the methionine was adjusted so that  the methionine concentration 
was the same as that in MEM (0.1 mM). At the end of the labeling 
period, the cells were rapidly washed once with 10 ml of methionine- 
free MEM. In some experiments, MEM which contained 0.1 mM 
nonradiactive methionine and 10% heat-inactivated fetal calf serum 
was then added for various times. The incubation was terminated by 
’ The abbreviations used are: AdoHcy, S-adenosylhomocysteine; 
AdoMet, S-adenosylmethionine; MEM, modified Eagle’s medium. 
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removal of the medium and addition of 2 ml of cold  5% sulfosalicylic 
acid to the cells in the dish. The sulfosalicylic acid suspension was 
removed and  the dish was rinsed twice with 1 ml each of 5 8  sulfosal- 
icylic acid. The sulfosalicylic acid suspension and  the two rinses were 
combined and centrifuged at 3,000 X g for 20 min at  4 "C. To 
determine the amount of % in AdoMet, AdoHcy, and 3-deaza- 
AdoHcy, the  supernatant was filtered through  either  a glass fiber or 
Millex (0.22 pmj filter and applied to a VYDAC (Applied Sciences 
1nc.j cation exchange column as described previously (20, 24). 
AdoHcy Hydrolase Assays in Sonicates-Cells were harvested 
and centrifuged a t  150 X g for 10 min at  25 "C. The pellet was washed 
twice with 10 ml each of Dulbecco's phosphate-buffered  saline  without 
magnesium or calcium and  suspended to approximately 1 X 10" cells/ 
ml in Hz0 at  25 "C. The suspension was cooled to 0 "C in an ice bath 
and sonicated in a water bath sonicator (Beckman model CC-25 
ultrasonic cleaner) for a total of 2 min in  30-s pulses. No intact cells 
remained after sonication. The sonicate was centrifuged at 1600 X g 
for 20 min at  4 "C. The supernatant, fluid was removed, adjusted to 10 
mM potassium phosphate  (pH 7.6). 0.07 mM sodium EDTA, and 2 
mM dithiothreitol,  and  stored at  -20 "C. 
AdoHcy hydrolysis was measured by conversion of [I4C]AdoHcy 
to [I4Cjinosine in the presence of excess adenosine deaminase as 
described previously (16). The reaction mixture (0.5 m l )  was com- 
posed of 150 mM potassium phosphate  (pH 7.6), 1.0 mM EDTA, 0.1 
mM ["CIAdoHcy, 2 units of adenosine deaminase (Type I; Sigma 
Chemical Co.), and sonicate. Synthesis of ["H]3-deaza-AdoHcy was 
measured after incubation of  20 PM ['H]3-deazaadenosine, 1 mM 
homocysteine, 11 m 4-(2-hydroxyethyl)-l-piperazineethanesulfonic 
acid (pH 7.6j, 1 nm EDTA, and sonicate at  37 "C in a total volume 
of 90 pl. Sonicate and homocysteine were preincubated in buffer for 
10 min at   3i  "C  and  the reaction was started by the addition of ['"HI 
3-deazaadenosine. After 20 min, the reaction was stopped by addition 
of 1 ml of  50 mM HCl at  0 "C.  ["H]3-deaza-AdoHcy and ['H]3- 
deazaadenosine were separated  on SP-Sephadex columns by modifi- 
cation of previously published methods (16,25j.  The reaction  mixture 
was applied to  an SP-Sephadex C-25 column (0.8 X 5 cm) equilibrated 
in 0.01 M HC1. [3Hj3-Deazaadenosine was washed from the column 
with 35 ml of 50 mM HC1 and ["Hldeaza-AdoHcy was subsequently 
eluted  into two scintillation vials with 10 ml of 1 N HC1. Hydrofluor 
(12 m l )  was added to each vial and the vials were counted in a 
scintillation counter. 
Chemicals-3-Deazaadenosine, 3-deazaaristeromycin, 5-deoxy-5'- 
(isobutylthio)-3-deazaadenosine, and r3Hj3-deazaadenosine were ob- 
tained from the  Southern Research Institute, Birmingham, AL.  ["C] 
AdoHcy was prepared according to  the method of de la Haba  and 
Cantoni (15). Sinefungin was obtained from Lilly Research  Labora- 
tories, Indianapolis, IN. 
RESULTS 
A number of compounds known to  inhibit AdoHcy hydro- 
lase, AdoMet synthetase,  or  methyltransferases were tested 
for  the  capacity  to  inhibit chemotaxis by a  mouse macrophage 
cell line, RAW264 (Table I). 3-Deazaadenosine,  a potent  in- 
hibitor of and  substrate for AdoHcy hydrolase (16),  and cyclo- 
leucine or  ethionine,  AdoMet  synthetase  inhibitors  (26),  in- 
hibited chemotaxis  in  a dose-dependent fashion  (Fig. 1). The 
most potent  inhibitor  was 3-deazaadenosine,  which inhibited 
chemotaxis a t  concentrations  as low as 30 pM. Structurally 
related  compounds  such  as 5"deoxy-5"(isobutylthio)-3-deaz- 
aadenosine ( 2 7 )  and 3-deazaaristeromycin had no effect on 
chemotaxis. I t  is especially noteworthy that i n  vitro, 3-de- 
azaaristeromycin is a more potent inhibitor of beef liver 
AdoHcy hydrolase than is 3-deazaadenosine.' Sinefungin, a 
compound that  structurally  may be  considered an analog of 
either AdoMet or AdoHcy and that in vitro is a potent 
inhibitor of a number of methyltransferases  (28), did not affect 
chemotaxis at nontoxic concentrations. 
Experiments were performed to  determine  whether  these 
compounds interacted with AdoHcy hydrolase in vivo and 
thereby caused changes in the  intracellular levels of AdoHcy 
and AdoMet.  Cells were prelabeled for 3 h with [35S]methio- 
nine to avoid any effects the various inhibitors may have  on 
' P. K. Chiang, personal communication. 
TABLE I 
Inhibition of chemotaxis 
RAW264 cells (3 x IOb/6-cm dish) were plated 18 h before the 
addition of inhibitor. The cells were incubated  with  inhibitor for 3-4 
h, harvested by scraping, and centrifuged. The cell pellet was resus- 
pended to 1.25 X lob cells/ml in MEN containing 10% heat-inacti- 
vated  fetal calf serum  and  inhibitor, and 40 yl were added to  the  top 
wells of a multiwell chemotaxis chamber. The  bottom wells contained 
inhibitors at  the same  concentration  as in the  top wells and  a 1:100 
dilution of endotoxin-activated mouse serum. 
Inhibitor Concentration of chemo- 
Inhihition 
taxis" range 
P M  
AdoHcy hydrolase 








Cycloleucine - h + 
Ethionine - h + 
Sinefungin 40-400 - 
Methylases 
" A compound was considered an inhibitor of chemotaxis only if 
inhibition increased writh increasing concentration of inhibitor and if 
inhibition was more than 50% at  the highest  concentration  tested. 
See Fig. 1. 
1 X 10.' M 5'-deoxy-5'-(isobutyIthio)-3-deazaadenosine was toxic 
to  the cells. 
tw 
d 
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FIG. 1. Inhibition of RAW264 macrophage  cell  line  chemo- 
taxis by  3-deazaadenosine,  ethionine,  and  cycloleucine. Cells 
were incubated with the inhibitor for 3-4 h before the chemotaxis 
assay. The figure shows the dose-response curves from two  different 
experiments. In  the control for the  3-deazaadenosine curve, 20,700 
cells (41%) migrated in response to the attractant and 400 ( < l % j  
migrated to diluent. In  the control for the ethionine and cycloleucine 
curues, 29,300 (59%) migrated in response to  the  attractant and 1,800 
( 4 5 )  migrated to diluent. 
the  uptake of [35S]methionine. I t  was determined  that  at 3 h, 
["5S]methionine was  in  isotopic steady  state  with [35S]AdoMet 
(not  shown). After  labeling, the cells were  washed and  incu- 
bated with medium containing nonradioactive methionine 
with or  without  addition of various  inhibitors. In  the  absence 
of inhibitor, LT5S]AdoMet decreased with a half-life of  26 min 
(Table 11) due  to  the utilization of ["'SIAdoMet for intracel- 
lular  methylations.  The  formation f ["'S]AdoHcy was  barely 
detectable, since the  products of the hydrolysis of AdoHcy are 
rapidly  metabolized. Partial inhibition of AdoHcy hydrolase 
would be expected to result: (a) in an  accumulation of [:j5S] 
AdoHcy; and ( 6 )  in a siower decline in ["SIAdoMet if the 
levels of AdoHcy are sufficient to inhibit transmethylation 
reactions. Moreover, in the case of 3-deazaadenosine, accu- 
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TABLE I1
Effect of inhibitors on AdoMet and AdoHcy 
RAW264 cells (3 X 106/6-cm dish) were labeled with 5 NCi/ml of ["Slmethionine in MEM without fetal calf serum for 3 h, washed, and 
incubated for the times indicated with MEM containing nonradioactLe methionine, inhibitors, and 10% heat-inactivated  fetal calf serum. 
AdoMet AdoHcv 3-Deaza-AdoHcv 
Inhibitor" 
0 rnin  15 min 60 rnin  120 min 0 rnin  15  rnin 60 min 120 min 15  rnin 60 rnin 
~ _ _ _ _ _  
dpm/lOh cells 
None 43,600  33,500  9.100  2,200  360  160  ND' ND 
3-Deazaadenosine 33,400  15,300  2,500  2,100  700  1,200 
3-Deazaaristeromycin 33,100  18,900  3,300  8,300 
5'-Deoxy-5'-(isobutyl- 33,800  13,200  260  130 
thio)-3-deazaadeno- 
sine 
The concentrations of the inhibitors were: 3-deazaadenosine, 30 p ~ ;  5'-deoxy-5'-(isobutylthio)-3-deazaadenosine, 0.2 m; and 3-deazaari- 
ND, was not accurately quantifiable. In some cases a  trace  amount was found. 
steromycin, 0.5 mM. 
mulation of 3-deaza-AdoHcy would be expected as a result of 
the utilization of this compound  by  AdoHcy  hydrolase in  the 
biosynthetic direction. Table I1 shows that  treatment of the 
cells with 3-deazaadenosine resulted  in  the  accumulation of 
[35S]AdoHcy and [35S]3-deaza-AdoHcy as well as a decrease 
in  the  rate of utilization of [35S]AdoMet. In  contrast,  since 3- 
deazaaristeromycin is not a substrate for  AdoHcy  hydrolase, 
only AdoHcy accumulated after treatment with this com- 
pound. For example, a t  60 min,  4 times  more [35S]AdoHcy was 
found  in cells treated with  3-deazaaristeromycin than in cells 
treated with 3-deazaadenosine. If total nucleosidylhomocy- 
steine  (AdoHcy + 3-deaza-AdoHcy) is considered, cells 
treated with 3-deazaaristeromycin showed 2.5 times more 
radioactivity in  AdoHcy than was  observed in  total nucleosi- 
dylhomocysteine  in cells treated  with 3-deazaadenosine. 
Since 0.03 mM 3-deazaadenosine inhibited  chemotaxis  and 
0.5 mM 3-deazaaristeromycin did not, and since both com- 
pounds  caused  an  accumulation of AdoHcy but only 3-deaz- 
TABLE 111 
Effect of 3-deazaadenosine on chemotaxis 
Cells were incubated with 100 p~ 3-deazaadenosine at 37 "C in 75- 
cm2 T-flasks. Cells  were harvested and chemotaxis to a 1:100 dilution 
of endotoxin-activated mouse serum was measured in a multiwell 
chemotaxis chamber for 4 h. 3-Deazaadenosine ( 1 0 0 ~ ~ )  was included 
in both the top and bottom wells of the chemotaxis chamber. In 
Experiment 1, the cells were preincubated with 3-deazaadenosine for 
3  h at 37 "C and for 2  h at 25 "C during preparation for the chemotaxis 
assay. In Experiment 2, the cells were preincubated with 3-deaza- 
adenosine at 37 "C for 5  h and for 2.5 h at 25 "C during preparation 
for the chemotaxis assay. 
Cell line 
Inhibition 
Experiment 1 Experiment 2 
% 
RA  W264 57 90 
RAW309CR 0 0 
aadenosine caused the intracellular formation of 3-deaza- 
AdoHcy, the  results  reported in Tables I and I1 suggest that 
inhibition of chemotaxis  in RAW264 cells is mediated by 3- 
deaza-AdoHcy and  not by AdoHcy. 
Evidence in  support of this conclusion was obtained when 
we examined the effects of 3-deazadenosine on chemotaxis by 
another mouse macrophage cell line, RAW309CR. The at- 
tractant specificity, time course of chemotaxis, and cell density 
dependence of chemotaxis  for RAW264 and RAW309CR are 
similar (21). However, RAW264 was inhibited by 100 p~ 3- 
deazaadenosine, whereas RAW309CR was not  inhibited  (Ta- 
ble 111). Viability of either cell line was not significantly 
affected by 100 p~ 3-deazaadenosine as judged by trypan blue 
exclusion, and  there was little or no effect on phagocytosis of 
IgG-coated sheep  red blood cells. 
The effect of 3-deazaadenosine on the accumulation of 
AdoHcy and 3-deaza-AdoHcy in the two macrophage cell 
lines is shown  in Table IV. In this experiment, the cells were 
labeled  with  [35S]methionine  in the  absence  and presence of 
30 p~ 3-deazaadenosine. The  uptake of [3sS]methionine was 
not  inhibited in either cell line, and  both cell lines  accumulated 
similar levels of AdoHcy; however, the  amount of 3-deaza- 
AdoHcy synthesized in RAW264 cells was 7 times greater 
than in RAW309CR cells. These  results  support  the conclu- 
sion that 3-deaza-AdoHcy is  the  inhibitor of chemotaxis in 
RAW264, and  that RAW309CR does not accumulate suffi- 
cient  3-deaza-AdoHcy to  inhibit  its  chemotactic response. The 
results suggest that AdoHcy  hydrolase from RAW264 is in- 
hibited by 3-deazaadenosine and, like the AdoHcy  hydrolase 
from beef liver (16), utilizes 3-deazaadenosine as a substrate 
for the synthesis of 3-deaza-AdoHcy, whereas the enzyme 
from RAW309CR is subject  to inhibition by 3-deazaadenosine 
but utilizes this adenosine  analog as a substrate less efficiently. 
To  test  this  interpretation, AdoHcy  hydrolase activity was 
measured in  sonicates. The  results (Fig. 2)  show that  sonicates 
from  both cell lines  hydrolyzed  AdoHcy  equally well and  that 
TABLE IV 
Effect of 3-deazaadenosine on AdoMet and AdoHcy 
Cells (3 X 10G/6-cm dish) were plated 18 h before the addition of 5 pCi/ml of ["Sjlmethionine in MEM with and without 30 p~ 3- 
deazaadenosine. The cells were labeled for 100 min and the radioactivity in AdoMet, AdoHcy, and 3-deaza-AdoHcy was determined. 
Cell line 3-Deaza- Methionine adenosine AdoMet AdoHcy 3-Deaza- 
Total 






- 287,800  30,500
- 193,300 26,100 
100 
4 0 0  
+ 367,500 43,600 3,700  9,800 13,500 
229,700 35,400 4,100  1,400 5,500 + 
Uptake of [3'S]methionine into whole cells. This was measured by counting an aliquot of the sulfosalicylic acid suspension before 
centrifugation. 
I ,  Calculated by addition of the disintegrations per min in AdoHcy and 3-deaza-AdoHcy. 
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this activity was inhibited to  the same degree by 3-deazaaden- 
osine. On the other hand, the sonicates from RAW309CR 
utilized 3-deazaadenosine as  a  substrate much less efficiently 
than  the enzyme  from RAW264 (Fig. 3). When sonicates were 
mixed and AdoHcy hydrolase activity was measured with 3- 
deazaadenosine as a  substrate,  the activity was additive, sug- 
gesting that  the RAW309CR sonicate did not contain inhibi- 
tors of 3-deaza-AdoHcy synthesis. 
DISCUSSION 
It is established that AdoHcy inhibits essentially all the 
reactions in  which  AdoMet participates as a  substrate;  there- 
fore a very large number of AdoHcy analogs have been syn- 
thesized in different laboratories (29) in the hope of discov- 
ering analogs that have greater specificity and that are capable 
of inhibiting only  one  or a limited number of AdoMet-depend- 
ent reactions. Indeed, when tested in uitro against different 
enzymes, the ratios of the inhibition constants for AdoHcy 
and AdoHcy analogs varied over a wide range (28). In vivo, 
however, the limited permeability of AdoHcy and its analogs 
represents a serious obstacle to  the pharmacological utiliza- 
tion of these compounds. Here we show for the first time that 
the intracellular accumulation of an AdoHcy  analog,  3-deaza- 
AdoHcy, can have biological effects that are different from 
those that can be demonstrated when intracellular levels of 
AdoHcy are experimentally increased. Therefore, it should be 
possible to  take advantage of the relatively broad specificity 
of AdoHcy hydrolase toward its purine substrate to generate 
inside the cells a variety of analogs of AdoHcy with inhibitory 
specificities that differ  from those of the  natural compound 
and with potentially valuable pharmacological activities. 
The present experiments provide additional evidence for 
the hypothesis that in eukaryotes, as in prokaryotes, biological 
methylation is involved in the chemotactic response. Both the 
inhibitory effects of 3-deazaadenosine and those of cycloleu- 
cine and ethionine are best explained by the single assumption 
that one (or more) enzymatic reaction(s) in which the methyl 
group of AdoMet is transferred to a suitable acceptor is 
necessary for chemotaxis by the RAW264 macrophage cell 
line. It can also be concluded that this reaction(s) is more 
sensitive to inhibition by 3-deaza-AdoHcy than by AdoHcy. 
It should be noted that Borchardt et al. (30) have shown that 
sinefungin and A9145C, compounds structurally related to 
AdoHcy, have inhibition constants for calf thymus protein 
carboxymethylase that  are 5-40 times lower than  the inhibi- 
tion constants for  AdoHcy. A recent report by Zimmerman et 
al. (31) indicates that accumulation of AdoHcy or 3-deaza- 
AdoHcy may perturb cyclic  AMP metabolism. However,  since 
inhibition of chemotaxis was  specifically related to accumu- 
pl ENZYME EXTRACT 
FIG. 2 (left). Inhibition of AdoHcy 
hydrolase activity in sonicates of 
RAW264 and RAW309CR cells. The 
was 27.1 pmol/min/106 cells for  RAW264 
activity in sonicates without inhibitors 
and 25.2 pmol/min/106 cells for 
RAW309CR. 
FIG. 3 (right). Formation of 3- 
deaza-AdoHcy in sonicates of 
RAW264 and RAW309CR cells. One 
microliter of sonicate was  prepared  from 
8.1 x IO4 RAW264 cells or 5.2 x lo4 
RAW309CR cells. On a per cell basis, 
hydrolysis of AdoHcy was essentially the 
same in both sonicates. 
lation of 3-deaza-AdoHcy, their observations are probably not 
relevant to our studies. 
As to  the  nature of the transmethylation reaction that is 
critically  involved in the chemotactic response in the cell  line 
studied, only conjecture is possible at this time. Carboxymeth- 
ylation has been  clearly  identified as  an essential feature of 
the mechanism of chemotaxis in bacteria (4-9). In vivo car- 
boxymethylation of membrane proteins in human erythro- 
cytes has been recently reported (32), but no  specific  biological 
function can as yet be ascribed to  this carboxymethylation 
reaction. 
A relationship of phospholipid methylation to eukaryotic 
chemotaxis has been postulated and it has been suggested 
that calmodulin, a protein that is a substrate for protein 
methylase, may modulate this reaction (33). Axelrod and his 
collaborators have advanced the hypothesis that phosphati- 
dylethanolamine methylation is essential to  a variety of phys- 
iological responses such as lymphocyte mitogenesis (34), his- 
tamine release by basophils and mast cells  (35-37), and leu- 
cocyte chemotaxis (12). However, as we will show  elsewhere, 
both 3-deazaadenosine and 3-deazaaristeromycin inhibit in- 
corporation of the methyl group of methionine into phospha- 
tidylcholine by  more than 90%  in  RAW264 cells, whereas we 
show  in this communication that administration of 3-deazaa- 
denosine, but not that of 3-deazaaristeromycin, causes inhi- 
bition of chemotaxis. 
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